AliveCor

AliveCor’s FDA-cleared personal ECG devices—including the single-lead KardiaMobile, six-lead KardiaMobile 6L, and credit-card-sized KardiaMobile Card—are widely used by consumers and healthcare professionals. Their products are supported by over 200 clinical publications. The company’s algorithms can detect six common arrhythmias with high accuracy; their devices are used globally in both consumer self-monitoring and professional settings. AliveCor has also received regulatory clearance to use its technology to monitor QTc intervals—a key safety concern in drug development—and partners with biopharma companies on remote cardiac safety monitoring.